{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:05:06Z","timestamp":1790240706845,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP20ak0101151"],"award-info":[{"award-number":["JP20ak0101151"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e30695","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T01:25:04Z","timestamp":1714872304000},"page":"e30695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuronal autoantibodies in the cerebrospinal fluid of 148 patients with schizophrenia and 151 healthy controls"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-9300","authenticated-orcid":false,"given":"Takako","family":"Enokida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanako","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hidese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ichi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-2317","authenticated-orcid":false,"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e30695_bib1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and Burden of schizophrenia: findings from the global Burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.heliyon.2024.e30695_bib2","first-page":"67","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality, Epidemiol","volume":"30","author":"McGrath","year":"2008","journal-title":"Rev"},{"key":"10.1016\/j.heliyon.2024.e30695_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e30695_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e30695_bib5","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/s41380-020-0654-3","article-title":"Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion","volume":"26","author":"Cleynen","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e30695_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.829058","article-title":"Catatonic schizophrenia associated with cerebrospinal GAD65 autoantibodies: case report and Literature review","volume":"13","author":"Hansen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000526425","article-title":"Autoantibodies against central nervous system antigens and the serum levels of IL-32 in patients with schizophrenia","volume":"29","author":"Keshavarz","year":"2022","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.heliyon.2024.e30695_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti\u2013N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in Epilepsy of Unknown Etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.mayocp.2021.07.023","article-title":"Autoimmune\/paraneoplastic encephalitis antibody biomarkers: Frequency, age, and sex Associations","volume":"97","author":"Kunchok","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.heliyon.2024.e30695_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib14","first-page":"116","article-title":"Current findings on the Spectrum of neuronal autoantibodies associated with psychotic disorders, J. Psychol. Psychother","volume":"10","author":"Hansen","year":"2023","journal-title":"Res."},{"key":"10.1016\/j.heliyon.2024.e30695_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1074\/mcp.M900513-MCP200","article-title":"In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification","volume":"9","author":"Mouton-Barbosa","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.heliyon.2024.e30695_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/2006\/158797","article-title":"Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges","volume":"22","author":"H\u00fchmer","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.heliyon.2024.e30695_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","article-title":"CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis","volume":"29","author":"Wang","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.heliyon.2024.e30695_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.clinbiochem.2016.11.023","article-title":"Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies","volume":"50","author":"Gastaldi","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.heliyon.2024.e30695_bib19","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, Neuroimmunologic, and CSF Investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2024.e30695_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41439-022-00217-6","article-title":"National center Biobank Network","volume":"9","author":"Omae","year":"2022","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.heliyon.2024.e30695_bib22","unstructured":"A.P. American Psychiatric Association, [PDF] Diagnostic And Statistical Manual Of Mental Disorders DSM-IV American Psychiatric Association -pdf download free book,(n.d.). https:\/\/www.gammaconstruction.mu\/sites\/default\/files\/webform\/cvs\/pdf-diagnostic-and-statistical-manual-of-mental-disorders-dsm-iv-american-psychiatric-association-pdf-download-free-book-9223cc7.pdf (accessed April 10, 2023).."},{"key":"10.1016\/j.heliyon.2024.e30695_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.heliyon.2024.e30695_bib24","first-page":"22","article-title":"Others, the Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e30695_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1440-1819.2005.01408.x","article-title":"Reliability and validity of Japanese version of the Mini-international Neuropsychiatric interview","volume":"59","author":"Otsubo","year":"2005","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e30695_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e30695_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep11412","article-title":"Increased cerebrospinal fluid fibrinogen in major depressive disorder","volume":"5","author":"Hattori","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e30695_bib28","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e30695_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e30695_bib30","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.heliyon.2024.e30695_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e30695_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbi.2019.06.017","article-title":"Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia","volume":"81","author":"Tong","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.heliyon.2024.e30695_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.schres.2022.12.029","article-title":"Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls","volume":"252","author":"Jeppesen","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.heliyon.2024.e30695_bib34","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mai.2000.107039","article-title":"Autoantibodies to DFS 70 kd\/transcription coactivator p75 in atopic dermatitis and other conditions","volume":"105","author":"Ochs","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib35","first-page":"464","article-title":"Anti-DFS70 antibodies are associated with atopic dermatitis and can cause misdiagnosis of connective tissue disease","volume":"21","author":"Santler","year":"2023","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.heliyon.2024.e30695_bib36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.20096","article-title":"Anti-DFS70 antibodies in 597 healthy hospital workers","volume":"50","author":"Watanabe","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.heliyon.2024.e30695_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in Adults","volume":"80","author":"Flanagan","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e30695_bib38","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/s41598-019-38686-5","article-title":"Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort","volume":"9","author":"Carbone","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e30695_bib39","article-title":"Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice","volume":"3","author":"Shiwaku","year":"2022","journal-title":"Cell Rep Med"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024067264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024067264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:27:55Z","timestamp":1790238475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024067264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024067264"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30695","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal autoantibodies in the cerebrospinal fluid of 148 patients with schizophrenia and 151 healthy controls","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e30695"}}